Tim Fell Email & Phone Number

Alderley Edge, Cheshire, GB

Alderley Edge, Cheshire, GB

Kinomica is a precision medicine company that is developing phosphoproteomic diagnostic tests to help clinicians to prescribe the right drug, for the right patient, at the right time.Measuring phosphorylation that regulates protein function can reveal the true protein activity and cell signalling pathways associated with disease. This will transform.

Stevenage, England, GB

MFX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy. Its automated, closed technology allows biologists to easily carry out process development by running dozens of cell culture conditions in parallel with extreme process control, and to scale up.

London, White City, GB

Synthace is unlocking the potential of biology for humankind and our environment. The company’s Life Sciences R&D Cloud is accelerating biological discovery and optimization; empowering biologists to flexibly program their lab automation without the need to code. Top global pharmaceuticals, high-growth biotech companies, leading CDMOs, and innovators in.

London, England, GB

The SBLC is a strategic co-ordinating body for the UK’s interests in the rapidly developing field of Synthetic Biology.

London, GB

Built a drug discovery business in the emerging field of Epigenetics based on a technology platform involving over 30 leading academic laboratories. Raised VC investment, govt. grant funding and secured multiple business deals and collaborations in US, Europe and Asia. Accountable for company strategy, operations, business development, financial plan and.

Co-led the life sciences team dedicated to helping R&D businesses form partnerships with universities.

GB

Member of the Executive Team with responsibility for discovery technologies throughout this anti-infective drug discovery company. Contributed to developing the company strategy and business plan prior to exit to AstraZeneca.

A spin-out from the University of Oxford providing highly flexible DNA microarrays and software to the Pharma industry based on ink-jet printer technology. Built and managed a team of programmers and bioinformaticians to create design and analysis software, and a multidisciplinary team of molecular biologists, chemists, and engineers to make DNA.

A member of Prof. Ed Southern’s research group developing his invention of DNA microarrays. Managed the fabrication, automation, detection and quality control aspects of the research, also contributing to the basic studies of the processes underpinning the technology. Litigated the ‘Southern Patents’ in the US and UK courts against Affymetrix Inc..

Continuation of doctoral research on the electrical properties of crystallographic defects in semiconductors. Acquired key skills in programming, micro-fabrication techniques, methods of analysis and electronics subsequently utilised in the cross-discipline development of DNA microarrays.

Executive Mba

D.Phil, Materials Science

Bsc, Materials Science